Ken Griffin
CANC icon

Ken Griffin’s Tema Oncology ETF CANC Stock Holding History

Ken Griffin’s Portfolio CANC Stock Details CANC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.54M Buy
+69,106
New +$2.52M ﹤0.01% 5589

Other funds holding CANC

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
WF
Willow Financial Rogers, Arkansas $98.7M AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
PIA
Perennial Investment Advisors Los Angeles, California $1.26B AUM 22.26% 1-Year Est. Return
RF
Roxbury Financial Mount Arlington, New Jersey $126M AUM 23.88% 1-Year Est. Return
TCM
TD Capital Management Memphis, Tennessee $1.22B AUM 13.44% 1-Year Est. Return

Ken Griffin's CANC Position: Q1 2026 in Review

Ken Griffin opened a new position in Tema Oncology ETF (CANC) in Q1 2026: 69,106 shares worth $2.54M. The stake represents ﹤0.01% of the portfolio and ranks #5589 among its holdings.

12 funds tracked by Wall St. Rank hold CANC as of Q1 2026.

  • Ken Griffin held 69,106 shares of Tema Oncology ETF worth $2.54M as of Q1 2026.
  • Tema Oncology ETF was a new Ken Griffin position in Q1 2026.
  • Tema Oncology ETF made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #5589 holding.
  • 12 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.